Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized with DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins

Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy

(2019) Nicole M. Maphis et al.   npj Vaccines

From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy

(2019) Morvane Colin et al.   ACTA NEUROPATHOLOGICA

Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins

(2018) Adrián Lázaro-Frías et al.   JOURNAL OF VIROLOGY

Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression

(2018) María Q. Marín et al.   Viruses-Basel

Structural Basis for Recognition of a Unique Epitope by a Human Anti-tau Antibody

(2018) Heng Zhang et al.   STRUCTURE

A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice

(2018) Patricia Pérez et al.   Scientific Reports

Alzheimer's disease

(2017) C. A. Lane et al.   EUROPEAN JOURNAL OF NEUROLOGY

Tau passive immunization inhibits not only tau but also Aβ pathology

(2017) Chun-ling Dai et al.   Alzheimers Research & Therapy

Alzheimer's Disease and the Amyloid-β Peptide

(2017) M. Paul Murphy et al.   JOURNAL OF ALZHEIMERS DISEASE

Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases

(2016) Tina Bilousova et al.   AMERICAN JOURNAL OF PATHOLOGY

Tau-positive nuclear indentations in P301S tauopathy mice

(2016) Marta Fernández-Nogales et al.   BRAIN PATHOLOGY

Vaccination to Alzheimer Disease. Is it a Promising Tool or a Blind Way?

(2016) Miroslav Pohanka   CURRENT MEDICINAL CHEMISTRY

Developing therapeutic vaccines against Alzheimer’s disease

(2015) Thomas Wisniewski et al.   Expert Review of Vaccines

Tau Immunotherapy

(2015) Einar M. Sigurdsson   Neurodegenerative Diseases

NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses

(2015) Mauro Di Pilato et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tau immunotherapy for Alzheimer's disease

(2015) Jan Torleif Pedersen et al.   TRENDS IN MOLECULAR MEDICINE

Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations

(2015) Jeremy J Kudrna et al.   Human Vaccines & Immunotherapeutics

New perspectives on the role of tau in Alzheimer's disease. Implications for therapy

(2014) Miguel Medina et al.   BIOCHEMICAL PHARMACOLOGY

A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection

(2014) J. Garcia-Arriaza et al.   JOURNAL OF VIROLOGY

Enhancing poxvirus vectors vaccine immunogenicity

(2014) Juan García-Arriaza et al.   Human Vaccines & Immunotherapeutics

Amyloid β and Tau Alzheimer’s disease related pathology is reduced by Toll-like receptor 9 stimulation

(2014) Henrieta Scholtzova et al.   Acta Neuropathologica Communications

Clinical applications of attenuated MVA poxvirus strain

(2013) Carmen Elena Gómez et al.   Expert Review of Vaccines

Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance

(2013) Erin E. Congdon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

High, Broad, Polyfunctional, and Durable T Cell Immune Responses Induced in Mice by a Novel Hepatitis C Virus (HCV) Vaccine Candidate (MVA-HCV) Based on Modified Vaccinia Virus Ankara Expressing the Nearly Full-Length HCV Genome

(2013) C. E. Gomez et al.   JOURNAL OF VIROLOGY

Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways

(2013) Juan García-Arriaza et al.   PLoS One

Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy

(2013) Clara Theunis et al.   PLoS One

Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies

(2013) Asisa Volz et al.   VACCINE

Neuropathological Alterations in Alzheimer Disease

(2013) A. Serrano-Pozo et al.   Cold Spring Harbor Perspectives in Medicine

A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses

(2011) Juan García-Arriaza et al.   PLoS One

Can Alzheimer disease be prevented by amyloid-β immunotherapy?

(2010) Cynthia A. Lemere et al.   Nature Reviews Neurology

Induction of Toll-Like Receptor 9 Signaling as a Method for Ameliorating Alzheimer's Disease-Related Pathology

(2009) H. Scholtzova et al.   JOURNAL OF NEUROSCIENCE